ALSO NOTED: Nigerian state won't negotiate with Pfizer; Novartis, Sun Pharma settle Exelon patent case;

> Nigeria's Kano state has ended settlement talks with Pfizer in the much-publicized case of a disputed meningitis drug trial; state officials also asked the country's federal government for help extraditing five Americans who allegedly took part in the trial. Report

> Novartis and Sun Pharma made a deal to settle patent litigation over Sun's generic version of the dementia drug Exelon, but the specific terms weren't disclosed. Report

> Ranbaxy Laboratories got regulatory approval to make and sell the anti-HIV drug Coviro for children in India. Report

> Thailand's Food and Drug Administration has proposed heavier fines on those who make, sell, and import counterfeit meds. Report

> The U.S. FDA eased some rules governing  a program that restricts prescriptions of the Accutane acne-fighting drug to women who are proven not to be pregnant. Report

And Finally... Honey may be an effective and safe alternative than over the counter children's cough medicines, according to a Penn State College of Medicine study. Release

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.